Multimeric-001 Universal Flu Vaccine: Phase I/II data

Data from a single-blind, placebo-controlled, dose-escalation, Israeli Phase I/II trial in 60 healthy volunteers ages 18-49 showed that 2 intramuscular injections of either low- or high-dose Multimeri...